Pharma News Articles

▼ Show details

MDLinx Pharma helps physicians and healthcare professionals stay up to date with the latest pharma news articles and research, as well as pharma jobs, conferences, and resources.

Ranked, sorted, and summarized by MDLinx editors from the latest literature

1 Daiichi Sankyo to acquire Ambit Biosciences Full Text Daiichi Sankyo, September 30, 2014

2 Pfizer completes acquisition Of InnoPharma Full Text Pfizer, September 30, 2014

3 Zytiga plus prednisone demonstrates statistically significant overall survival after 49-month follow-up analysis in chemotherapy-naïve men with metastatic castration-resistant prostate cancer Full Text Johnson & Johnson, September 30, 2014

4 Genentech’s investigational combination of cobimetinib plus Zelboraf (vemurafenib) provided significant benefit to people with advanced melanoma over Zelboraf alone Full Text Genentech, September 30, 2014

5 Genentech’s perjeta regimen extended the lives of people with an aggressive type of metastatic breast cancer by 15.7 months compared to Herceptin and chemotherapy Full Text Genentech, September 30, 2014

6 Weekly and every 2 weeks cetuximab maintenance therapy after platinum-based chemotherapy plus cetuximab as first-line treatment for non-small cell lung cancer: Randomized non-comparative phase IIIb NEXT trial Targeted Oncology, September 30, 2014    Clinical Article

7 Abbott completes acquisition of CFR pharmaceuticals; announces results of tender offer for CFR shares Abbott, September 30, 2014

8 Amgen to host summary webcast of Kyprolis (carfilzomib) for injection data presented at The European Society for Medical Oncology (ESMO) 2014 Congress Full Text Amgen, September 30, 2014

9 Top 3 skills for clinical trial project manager Full Text Applied Clinical Trials, September 30, 2014

10 Head-to-head Phase III trial demonstrates superior progression-free survival for afatinib compared to erlotinib in patients with advanced squamous cell carcinoma of the lung Full Text Boehringer Ingelheim, September 30, 2014

11 ARIAD presents updated clinical data on AP26113 in patients with ALK+ non-small cell lung cancer Full Text ARIAD Pharmaceuticals, September 30, 2014

12 Sarepta Therapeutics to present at Leerink Partners Rare Disease Roundtable Full Text Sarepta Therapeutics, September 30, 2014

13 IRESSA receives CHMP positive opinion to include blood based diagnostic testing in European label Full Text AstraZeneca, September 30, 2014

14 MOVENTIG (naloxegol) receives positive CHMP opinion in the EU for the treatment of adults with opioid-induced constipation Full Text AstraZeneca, September 30, 2014

15 Nintedanib receives positive CHMP opinion for second-line treatment of patients with adenocarcinoma of the lung Full Text Boehringer Ingelheim, September 30, 2014

16 GSK announces overall survival results from phase III BREAK-3 study of Tafinlar (dabrafenib) in patients with BRAF V600E-mutant metastatic melanoma Full Text GlaxoSmithKline, September 30, 2014

17 Seattle Genetics and Takeda announce positive data from phase 3 AETHERA clinical trial of ADCETRIS (brentuximab vedotin) for consolidation in post-transplant Hodgkin's lymphoma Full Text Millennium Pharmaceuticals, September 30, 2014

18 MedImmune and Cancer Research UK establish joint CRUK-MEDI alliance laboratory to develop new biologic cancer medicines Full Text MedImmune, September 30, 2014

19 Glyaderm dermal substitute: Clinical application and long-term results in 55 patients Burns, September 30, 2014    Clinical Article

20 Did the health of the Dutch population improve between 2001 and 2008? Investigating age- and gender-specific trends in quality of life The European Journal of Health Economics, September 30, 2014    Clinical Article

50 available pages FirstPrevious 1 2 3 4 5 6 7 8 9 10 Next Last
Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Other Topics in Pharma News

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register
Upcoming Clinical Trials UPCOMING Clinical Trials

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More